---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-061038"
form_type: "8-K"
ticker: "ABVC"
cik: "0001173313"
company_name: "ABVC BIOPHARMA, INC."
filed_at: "2023-07-31T23:59:59+00:00"
generated_at: "2026-06-12T21:46:56.921689+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ABVC BioPharma closes $1.75M registered direct offering of common stock and pre-funded warrants

## Summary
- Offering of 500,000 shares/pre-funded warrants at $3.50/share to a single institutional investor.
- Gross proceeds of $1.75 million before fees; net proceeds for R&D, working capital, and debt repayment.
- Wilmington Capital Securities acted as placement agent; offering through existing shelf registration.
- Closing occurred July 31, 2023, with all conditions satisfied.

## SEC filing metadata
- accession: 0001213900-23-061038
- form_type: 8-K
- ticker: ABVC
- cik: 0001173313
- company_name: ABVC BIOPHARMA, INC.
- filed_at: 2023-07-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1173313/000121390023061038/0001213900-23-061038-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1173313/000121390023061038/ea182578-8k_abvcbio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-061038
- JSON: https://secwatch.observer/filing/0001213900-23-061038.json
- Plain text: https://secwatch.observer/filing/0001213900-23-061038.txt

## Key facts
- Material Agreements
  ABVC BIOPHARMA, INC. entered into SPA with a certain institutional investor (effective 2023-07-27).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: a certain institutional investor
  - Effective: 2023-07-27
  source text: the Company entered into certain securities purchase agreement, dated July 27, 2023 (the “ SPA ”), with a certain institutional investor (the “ Purchaser ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1173313/000121390023061038/0001213900-23-061038-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.